生产管理员\工艺员

成都康弘药业集团股份有限公司

Chinese pharmaceutical group founded in 1996 in Chengdu, Sichuan and listed on the Shenzhen Stock Exchange under code 002773 since 26 June 2015. Researches, manufactures, sells and supports biologics, traditional Chinese medicines, chemical drugs and medical devices from its own research centre and standardised production bases, with a nationwide sales network. Its best known product is conbercept ophthalmic injection, added to China's national reimbursement list in 2017 and still growing, and by the end of 2024 the group held 336 granted patents including 283 invention patents.